Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Lupus Erythematosus (CLE)”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Large-scale testing (Phase 3)Study completedNCT00470912
What this trial is testing

Sunscreen RV 2457C in Photoinduced CLE

Who this might be right for
Cutaneous Lupus ErythematosusSkin LesionExperimental Photoinduction+1 more
Heinrich-Heine University, Duesseldorf 25
Early research (Phase 1)Not Yet RecruitingNCT07455578
What this trial is testing

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Who this might be right for
Autoimmune DiseasesRheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)+3 more
Seismic Therapeutic AU Pty Ltd 24
Not applicableLooking for participantsNCT06411106
What this trial is testing

Deep Phenotyping of Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
Centre for Human Drug Research, Netherlands 40
Testing effectiveness (Phase 2)Study completedNCT02847598
What this trial is testing

Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusActive Cutaneous Lupus Erythematosus
Biogen 264
Not applicableLooking for participantsNCT01510067
What this trial is testing

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 700
Not applicableLooking for participantsNCT06927219
What this trial is testing

Research Accelerated by You Lupus Registry

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Cutaneous Lupus Erythematosus (CLE)
Lupus Foundation of America 10,000
Testing effectiveness (Phase 2)Ended earlyNCT05629208
What this trial is testing

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Gilead Sciences 20
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Early research (Phase 1)Not Yet RecruitingNCT07306585
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
HC Biopharma Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06980805
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Immunovant Sciences GmbH 56
Not applicableLooking for participantsNCT01266915
What this trial is testing

Cutaneous Lupus Registry

Who this might be right for
Lupus Erythematosus
University of Texas Southwestern Medical Center 1,000
Large-scale testing (Phase 3)Looking for participantsNCT07355218
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Who this might be right for
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 202
Testing effectiveness (Phase 2)Study completedNCT00317681
What this trial is testing

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Heinrich-Heine University, Duesseldorf 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06965244
What this trial is testing

Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Assistance Publique - Hôpitaux de Paris 122
Large-scale testing (Phase 3)Looking for participantsNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07440537
What this trial is testing

Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Beijing InnoCare Pharma Tech Co., Ltd. 105
Early research (Phase 1)Study completedNCT04647708
What this trial is testing

Study of M5049 in CLE and SLE Participants

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus Erythematosus
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 25
Not applicableStudy completedNCT00633945
What this trial is testing

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 5
Load More Results